MYGN - Myriad Genetics $25.88
Myriad Genetics (NASDAQ:MYGN) is a biopharmaceutical company
focused on the development of novel therapeutic products and
the development and marketing of predictive medicine products.
The company's researchers have made important discoveries in
the fields of cancer, Alzheimer's disease, viral diseases (such
as HIV), depression and obesity.
Sell Put FEB 22.50 GSQ-NX
Bid = $0.45 Open Interest = 160
Potential Profit (5 contracts) = $225
Return on Investment (max) = 5.8%
Cost Basis in Stock = $22.05
Days to Expiration = 32